EUVIMEDEUVIMED entdecken
Crossref

Phillyrin: A potential therapeutic agent for osteoarthritis via modulation of NF-κB and Nrf2 signaling pathways

Jiawei Ma, Ze Wang, Yun Sun, Rukang Zheng, Hongye Tan, Hanwen Zhang, Zebin Jin, Yaosen Wu, Zeming Sun

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Jiawei Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325088, Zhejiang Pro…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Osteoarthritis, Signal Transduction, Chondrocytes. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Zhejiang Province Science and Technology Department, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is the predominant cause of disability among elderly people worldwide and is characterized by cartilage degeneration and excessive bone formation. Phillyrin, derived from forsythia, is a key extract renowned for its pronounced antibacterial and anti-inflammatory effects. Forsythia, deeply integrated into traditional Oriental medicine, has historically been utilized for its various pharmacological effects, including antibacterial, anti-inflammatory, and hepato-protective properties. Nevertheless, the anti-inflammatory impact of phillyrin on the progression of osteoarthritis remains enigmatic. The objective of this research was to assess the anti-inflammatory and anti-aging properties of phillyrin in mouse chondrocytes induced by IL-1β, as well as to elucidate the fundamental mechanisms underlying the phenomenon at play. Additionally, the investigation extends to observing the impact of phillyrin by establishing a murine osteoarthritic model. The ultimate goal was to identify phillyrin as a potential antiosteoarthritic agent. This investigation employs a multifaceted approach. Initially, key action targets of phillyrin, along with its probable action pathways, were identified by molecular docking and network pharmacological techniques. These findings were subsequently confirmed through both in vivo and in vitro studies. Network pharmacological analysis revealed NFE2L2 (NRF2), NFKB1, TLR4, and SERPING1 as pivotal candidate targets for the treatment of osteoarthritis with phillyrin. Molecular docking revealed hydrogen bond interactions between phillyrin and Arg415, Arg483, Ser508, and Asn387 on the Nrf2 receptor, while electrostatic interactions occurred with residues Arg415 and Arg380. Experiments conducted in vitro indicated that phillyrin preconditioning hindered the IL-1β-induced expression of proinflammatory factors which included TNF-α, COX-2, IL-6, and iNOS. Furthermore, phillyrin counteracts the IL-1β-induced degradation of aggrecan and collagen II within the extracellular matrix (ECM). This protective action is caused by the inhibition of the NF-κB pathway by phillyrin. Additionally, the mitigation of chondrocyte aging by phillyrin was observed. Our investigation revealed that phillyrin mitigates inflammation and counteracts cartilage degeneration in osteoarthritis (OA) patients by suppressing inflammation in chondrocytes and impeding aging through suppression of the NF-κB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2OsteoarthritisSignal TransductionChondrocytesNF-kappa BAnti-Inflammatory AgentsAnimalsMiceMaleOleanolic AcidInterleukin-1betaMolecular Docking SimulationMice, Inbred C57BLCells, CulturedHumansGlucosides

Stichwörter der Autor:innen

Anti-inflammatoryNF-κB signaling pathwayOsteoarthritisPhillyrinSenescence

Substanzen

NF-E2-Related Factor 2NF-kappa BAnti-Inflammatory AgentsNfe2l2 protein, mousephillyrinOleanolic AcidInterleukin-1betaGlucosides

Autor:innen und Institutionen

  • Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325088, Zhejiang Province, China; Zhejiang Provincial Key Laboratory of Orthopedics, Wenzh…

Förderung

  • Zhejiang Province Science and Technology Department
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Ma, J., Wang, Z., Sun, Y., Zheng, R., Tan, H., Zhang, H., Jin, Z., Wu, Y., & Sun, Z. (2024). Phillyrin: A potential therapeutic agent for osteoarthritis via modulation of NF-κB and Nrf2 signaling pathways. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112960

Vancouver

Ma J, Wang Z, Sun Y, Zheng R, Tan H, Zhang H, et al. Phillyrin: A potential therapeutic agent for osteoarthritis via modulation of NF-κB and Nrf2 signaling pathways. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112960

BibTeX
@article{Ma2024,
  author = {Ma, Jiawei and Wang, Ze and Sun, Yun and Zheng, Rukang and Tan, Hongye and Zhang, Hanwen and Jin, Zebin and Wu, Yaosen and Sun, Zeming},
  title = {Phillyrin: A potential therapeutic agent for osteoarthritis via modulation of NF-κB and Nrf2 signaling pathways},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112960}
}
Kostenlos starten →